Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sasieni

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Epidemiology (Cambridge, Mass.)|December 25, 2002
On the expected number of cancer deaths during follow-up of an initially cancer-free cohortPeter Sasieni
The Lancet. Oncology|January 1, 2022
Alternative analysis of the data from a HPV vaccine study in IndiaPeter Sasieni
The Lancet. Gastroenterology & Hepatology|July 12, 2019
Equality and equity in medical screening: what is fair?Peter Sasieni
Journal of Medical Screening|April 2, 2010
Has cytology become obsolete as a primary test in screening for cervical cancer?Peter Sasieni
Evidence-Based Medicine|May 3, 2014
The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over timePeter Sasieni
Best Practice & Research. Clinical Obstetrics & Gynaecology|January 3, 2006
Chemoprevention of cervical cancerPeter Sasieni
Lancet (London, England)|November 13, 2007
Cervical cancer prevention and hormonal contraceptionPeter Sasieni
Journal of Medical Screening|November 13, 2019
Flexible use of flexible sigmoidoscopyPeter Sasieni
BMJ Open|January 26, 2019
Impact of screening on cervical cancer incidence in England: a time trend analysisFrancesca Pesola, Peter Sasieni
Journal of Medical Screening|October 25, 2012
Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24Peter Sasieni, Alejandra Castanon
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Epidemiology (Cambridge, Mass.)|December 25, 2002
On the expected number of cancer deaths during follow-up of an initially cancer-free cohortPeter Sasieni
The Lancet. Oncology|January 1, 2022
Alternative analysis of the data from a HPV vaccine study in IndiaPeter Sasieni
The Lancet. Gastroenterology & Hepatology|July 12, 2019
Equality and equity in medical screening: what is fair?Peter Sasieni
Journal of Medical Screening|April 2, 2010
Has cytology become obsolete as a primary test in screening for cervical cancer?Peter Sasieni
Evidence-Based Medicine|May 3, 2014
The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over timePeter Sasieni
Best Practice & Research. Clinical Obstetrics & Gynaecology|January 3, 2006
Chemoprevention of cervical cancerPeter Sasieni
Lancet (London, England)|November 13, 2007
Cervical cancer prevention and hormonal contraceptionPeter Sasieni
Journal of Medical Screening|November 13, 2019
Flexible use of flexible sigmoidoscopyPeter Sasieni
BMJ Open|January 26, 2019
Impact of screening on cervical cancer incidence in England: a time trend analysisFrancesca Pesola, Peter Sasieni
Journal of Medical Screening|October 25, 2012
Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24Peter Sasieni, Alejandra Castanon
Pageof 21